Ann: Change of Director's Interest Notice - Dr James Garner, page-8

I really can't think of a better set up at this end of the ASX than what we have here. Trading below cash backing, with plenty of cash in the bank , with a full on drug development team on board and highly committed professional management with real skin in the game, and with interest rates about to start heading meaningfully lower. And in a sector where if things go well you can make serious returns, we are not here to make 5-7% per annum. I don't like it when things look this obvious, suggests I'm missing something, but until then opportunity knocks.